Chartwell Southern New England, Llc
Home Infusion Therapy Pharmacy
80 Clark Dr, Unite 1-a, East Berlin
Connecticut, 06023-1157
800-755-1511 860-828-0029
Chartwell Southern New England, Llc is not a DME supplier for medicare equipments and products.
Chartwell Southern New England, Llc is a Home Infusion Therapy Pharmacy in East Berlin, Connecticut. It is located at 80 Clark Dr, Unite 1-a, East Berlin and it's customer support contact number is 800-755-1511. The authorized person of Chartwell Southern New England, Llc is Joseph Bonaccorsi, JD who is Managing Member of the pharmacy and his contact number is 847-229-7794. Active license number of Chartwell Southern New England, Llc is 1385 for Home Infusion Therapy Pharmacy in Connecticut.
Chartwell Southern New England, Llc is pharmacy-based, decentralized patient care organization with expertise in USP 797-compliant sterile drug compounding that provides care to patients with acute or chronic conditions generally pertaining to parenteral administration of drugs, biologics and nutritional formulae administered through catheters and/or needles in home and alternate sites. Extensive professional pharmacy services, care coordination, infusion nursing services, supplies and equipment are provided to optimize efficacy and compliance.
Pharmacy Details:
Chartwell Southern New England, Llc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Chartwell Southern New England, Llc |
| Type: | Home Infusion Therapy Pharmacy |
| Location: | 80 Clark Dr, Unite 1-a, East Berlin, Connecticut, 06023-1157 |
| Phone: | 800-755-1511 |
| Fax: | 860-828-0029 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Joseph Bonaccorsi |
| Credentials: | JD |
| Position: | Managing Member |
| Contact Number: | 847-229-7794 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1790725588 |
| NPI Enumeration Date: | 08 Jun, 2006 |
| NPI Last Update On: | 19 Jan, 2009 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chartwell Southern New England, Llc are as mentioned below.
| Specialization | License Number | State | Status | |
| Home Infusion Therapy Pharmacy | 1385 | Connecticut | Primary | |
| Parenteral & Enteral Nutrition | 1385 | Connecticut | Secondary | |
| Community/Retail Pharmacy | 1385 | Connecticut | Secondary | |
| Durable Medical Equipment & Medical Supplies | 1385 | Connecticut | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 004129822 | Medicaid | Connecticut | |
| 004131132 | Medicaid | Connecticut | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 3026 Paysphere Cir, Chicago, Illinois |
| Zip: | 60674-0030 |
| Phone Number: | 800-879-6137 |
| Fax Number: | 847-913-9024 |
Patients can reach Chartwell Southern New England, Llc at
80 Clark Dr, Unite 1-a, East Berlin, Connecticut or can
call on customer care at 800-755-1511.
Comments/ Reviews:
Read all the reviews posted for Chartwell Southern New England, Llc below. You may also share your own experience with Chartwell Southern New England, Llc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.